Japan Cancels Rest Of H1N1 Flu Vaccine Ordered From GSK
This article was originally published in PharmAsia News
Executive Summary
Japan negotiated cancellation of part of its order of H1N1 flu vaccine from U.K.-based GlaxoSmithKline because the nation still has vaccine left over from the pandemic